Platelet-derived growth factor receptor inhibitor imatinib mesylate and docetaxel: A modular phase I trial in androgen-independent prostate cancer [14]

Matthias D. Hofer*, Mark A. Rubin

*Corresponding author for this work

Research output: Contribution to journalLetterpeer-review

2 Scopus citations
Original languageEnglish (US)
Pages (from-to)1332-1333
Number of pages2
JournalJournal of Clinical Oncology
Issue number6
StatePublished - Feb 20 2005

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Cite this